REDWOOD CITY, Calif., April 7, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that Randy Scott, Ph.D., Genomic Health's Chairman and Chief Executive Officer, will participate in a panel discussion titled, "The Transformation of the Biomedical Marketplace," at the BIO 2006 National Convention in Chicago, IL on Monday, April 10, 2006 at 11:00 AM Central Time (12:00 PM Eastern).
About Genomic Health
Genomic Health, Inc. is a life science company focused on the development and commercialization of genomic-based clinical diagnostic tests for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched its first test, Oncotype DX(TM), which has been shown to predict the likelihood of breast cancer recurrence and chemotherapy benefit in early stage breast cancer patients. The company was founded in 2000 and is located in Redwood City, California. For more information, please visit www.genomichealth.com.
SOURCE Genomic Health, Inc.
Brad Cole of Genomic Health, Inc., +1-650-569-2281, or firstname.lastname@example.org; or media, Emily Faucette of WeissComm Partners, +1-415-946-1066, or email@example.com, for Genomic Health, Inc.
Copyright (C) 2006 PR Newswire. All rights reserved.
News Provided by COMTEX